Agios Pharmaceuticals News and Activities

Agios Pharmaceuticals is owned by Sagard Holdings. Sagard Holdings has a direct presence in 4 countries.

Sagard Holdings has 11 subsidiaries including Acheel, Achieve and ADIT.

They are in:

• Insurance25%
• Financial Services17%
• Other58%

View the org chart displaying its 21 main executives

Most searched biographies at Agios Pharmaceuticals

• Brian Goff, Chief Executive Officer and Director
• Maykin Ho, Director
• Catherine Owen, Director

Popular executive movements at Sagard Holdings

• Kris Hansen, Chief Technology Officer, has left the company  (posted on January 5 2026).

Create your alert
to follow the executive moves at Agios Pharmaceuticals.

Sagard Holdings has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Agios Pharmaceuticals

• Agios to Webcast Conference Call of Third Quarter 2020 Financial Results on November 5, 2020 | Agios Pharmaceuticals, Inc.
• Agios Announces Withdrawal of European Marketing Authorization Application for TIBSOVO® as a Treatment for Relapsed or Refractory IDH1-mutant Acute Myeloid Leukemia | Agios Pharmaceuticals, Inc.
• Agios Announces Final Overall Survival Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Previously Treated IDH1-Mutant Cholangiocarcinoma Patients | Agios Pharmaceuticals, Inc.
• Agios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs | Agios Pharmaceuticals, Inc.
• Agios to Present at the Citi 15th Annual BioPharma Virtual Conference on Wednesday, September 9, 2020 | Agios Pharmaceuticals, Inc.
• Agios to Present at the Virtual Canaccord 40th Annual Growth Conference on Thursday, August 13, 2020 | Agios Pharmaceuticals, Inc.
• Agios Reports Business Highlights and Second Quarter 2020 Financial Results | Agios Pharmaceuticals, Inc.
• Agios to Webcast Conference Call of Second Quarter 2020 Financial Results on July 30, 2020 | Agios Pharmaceuticals, Inc.
• Agios to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference on Tuesday, June 23, 2020 | Agios Pharmaceuticals, Inc.
• Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Thalassemia | Agios Pharmaceuticals, Inc.
• View more press releases Close

Social media about Agios Pharmaceuticals

• Agios Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Agios Pharmaceuticals on LinkedIn, X (Twitter) & YouTube